Skip to main content
. 2021 Jul 28;12:676016. doi: 10.3389/fimmu.2021.676016

Table 1.

Comparison of the nature of dysbiosis reported in different studies in patients with MS.

Country Subjects (n = those with MS) Bacteria increased in MS Bacteria decreased in MS Reference
USA RRMS n=31 Pseudomonas, Mycoplana, Haemophilus, Blautia, Dorea, Pedobacter, Flavobacterium Prevotella, Parabacteroides, Adlercreutzia, Collinsella, Lactobacillus, Coprobacillus, Haemophilius (11)
USA RRMS n=60 Methanobrevibacter, Akkermansia Butyricimonas, Prevotella (12)
USA RRMS n= 43 Ruminococcus Fecalibacterium (10)
USA RRMS n=7 Akkermansia, Acinetobacter (5)
Germany MS twins n=34 (each twin pair had 1 with MS and one healthy) Akkermansia (6)
UK RRMS n=39 Prevotella copri (13)
Japan RRMS n=20 Bifidobacteria, Streptococcus, Thermophilus, Eggerthella lenta Bacteroides, Fecalibacterium, Prevotella, Anaerostipes, Clostridium, Sutterella (14)
China RRMS n=34 Streptococcus Prevotella (15)
Germany RRMS and SPMS Akkermansia, Faecalibacteria Butyricimonas, Bacteroides, Romboutsia (16)
Japan RRMS n=62, SPMS n=15, Atypical MS n= 21, Controls n=55 RRMS: Bifidobacteria, Streptococcus. RRMS: Megamonas (17)
SPMS: Streptococcus SPMS: Roseburia

Adapted from (1517).